Chewy
CHWY
18.22
+0.08
+0.44%
Chewy
US · CHWY
#1737 by market cap
Listed 2019
18.22
+0.08
+0.44%
Live - 5344 symbols - heartbeat 197s ago
· 2026-10-08 08:35
Pre-market
18.08
-0.77%
After-hours
18.30
+0.42%
Overnight
18.23
+0.05%
- Market cap
- 7.32B
- P/E (TTM)i
- 28.03
- P/Bi
- 19.76
- EPSi
- 0.52
- Div yieldi
- 0.00%
- 52W posi
- 4%
Reader sentiment
Are you bullish or bearish on CHWY?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.86, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +6.24% YoY
Margins
- Gross margin
- 29.79%
- Operating margin
- 2.02%
- Net margin
- 1.77%
Key ratios & quality
- PEG ratioi
- 0.43
- Altman Z-Scorei
- 4.86
PEG uses trailing P/E against the 3-year net income growth rate (64.67%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.53B | 4.85B | 7.15B | 8.97B | 10.12B | 11.15B | 11.86B | 12.60B |
| Gross profit | 714.81M | 1.14B | 1.82B | 2.39B | 2.83B | 3.16B | 3.47B | 3.75B |
| Selling & admin expenses | 982.57M | 1.40B | 1.91B | 2.46B | 2.78B | 3.19B | 3.36B | 3.50B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | -267.77M | -252.73M | -90.46M | -73.57M | 56.42M | -23.60M | 112.60M | 254.30M |
| Pretax profit | -267.89M | -252.37M | -92.49M | -75.21M | 52.55M | 48.30M | 151.70M | 263.30M |
| Tax | 0 | 0 | 0 | 0 | 2.65M | 8.70M | -241.00M | 40.50M |
| Net profit | -267.89M | -252.37M | -92.49M | -75.21M | 49.90M | 39.60M | 392.70M | 222.80M |
| Basic EPS | -1 | -1 | 0 | 0 | 0 | 0 | 1 | 1 |
| Diluted EPS | -0.68 | -0.63 | -0.23 | -0.18 | 0.12 | 0.09 | 0.91 | 0.52 |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-01 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Revenue | 3.12B | 3.10B | 3.12B | 3.26B | 3.36B | 3.33B |
| Gross profit | 923.80M | 942.20M | 928.20M | 959.70M | 1.01B | 1.01B |
| Selling & admin expenses | 846.90M | 872.50M | 863.00M | 917.20M | 882.90M | 919.20M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 76.90M | 69.70M | 65.20M | 42.50M | 128.50M | 92.00M |
| Pretax profit | 77.90M | 74.00M | 69.30M | 42.10M | 131.30M | 111.90M |
| Tax | 15.50M | 12.00M | 10.10M | 2.90M | 36.50M | 31.40M |
| Net profit | 62.40M | 62.00M | 59.20M | 39.20M | 94.80M | 80.50M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.15 | 0.14 | 0.14 | 0.09 | 0.23 | 0.20 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 448.59M | 629.79M | 1.23B | 1.32B | 1.52B | 2.10B | 1.66B | 2.04B |
| Cash & ST investments | 88.33M | 212.09M | 563.35M | 603.08M | 678.59M | 1.13B | 596.70M | 878.80M |
| Inventory | 220.86M | 317.81M | 513.30M | 560.43M | 678.01M | 719.27M | 836.70M | 864.80M |
| Total assets | 541.62M | 932.32M | 1.74B | 2.09B | 2.52B | 3.19B | 3.01B | 3.37B |
| Total current liabilities | 814.03M | 1.10B | 1.38B | 1.64B | 1.83B | 2.11B | 2.21B | 2.30B |
| Short-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 877,564,000.00 | 1,336,295,000.00 | 1,742,914,000.00 | 2,071,545,000.00 | 2,359,550,000.00 | 2,676,607,000.00 | 2,753,000,000.00 | 2,868,500,000.00 |
| Total equity | -335.94M | -403.97M | -2.00M | 14.74M | 160.27M | 510.24M | 261.50M | 497.90M |
| Retained earnings | -1.59B | -1.84B | -1.94B | -2.01B | -2.02B | -1.98B | -1.58B | -1.36B |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-01 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Total current assets | 1.71B | 1.78B | 1.93B | 2.04B | 1.84B | 1.85B |
| Cash & ST investments | 616.40M | 591.80M | 701.50M | 878.80M | 520.10M | 612.20M |
| Inventory | 806.90M | 874.60M | 943.90M | 864.80M | 1.01B | 924.70M |
| Total assets | 3.06B | 3.12B | 3.29B | 3.37B | 3.30B | 3.74B |
| Total current liabilities | 2.14B | 2.19B | 2.26B | 2.30B | 2.34B | 2.20B |
| Short-term debt | -- | -- | -- | -- | -- | 3.00M |
| Long-term debt | -- | -- | -- | -- | -- | 588.70M |
| Total liabilities | 2,684,700,000.00 | 2,728,900,000.00 | 2,825,200,000.00 | 2,868,500,000.00 | 2,879,500,000.00 | 3,370,100,000.00 |
| Total equity | 375.60M | 389.90M | 469.40M | 497.90M | 424.20M | 370.50M |
| Retained earnings | -1.52B | -1.46B | -1.40B | -1.36B | -1.27B | -1.18B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -13.42M | 46.58M | 132.76M | 191.74M | 349.78M | 486.20M | 596.30M | 691.60M |
| Depreciation & amortization | 23.21M | 30.65M | 35.66M | 55.32M | 83.44M | 109.70M | 114.60M | 129.30M |
| Free cash flow | -57.58M | -2.06M | 2.01M | 8.56M | 119.47M | 342.90M | 452.50M | 562.40M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 110.35M | 318.39M | -- | 0 | 0 | -942.80M | -262.50M |
| Ending cash balance | 88.33M | 212.09M | 563.35M | 604.10M | 331.64M | 602.20M | 595.80M | 860.10M |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-01 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| Operating cash flow | 86.40M | 133.90M | 207.90M | 263.40M | 108.50M | 137.40M |
| Depreciation & amortization | 30.00M | 32.10M | 32.80M | 34.40M | 37.00M | 39.70M |
| Free cash flow | 48.70M | 105.90M | 175.80M | 232.00M | 70.80M | 89.50M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -23.10M | -129.50M | -54.90M | -55.00M | -200.00M | -200.00M |
| Ending cash balance | 616.40M | 591.80M | 675.40M | 860.10M | 485.20M | 611.00M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -1,159.55 | 43.06 | 10.93 | 101.78 | 58.68 |
| ROA %i | -51.28 | -34.24 | -6.92 | -3.86 | 2.14 | 1.39 | 12.67 | 6.98 |
| ROIC %i | -- | -- | -- | -19.65 | 8.87 | -0.98 | 40.52 | 23.58 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -- | -190.42 |
| EBIT margin %i | -7.58 | -5.21 | -1.27 | -0.81 | 0.55 | 0.46 | 1.33 | 2.13 |
| FCF / sales %i | -- | -- | 0.03 | 0.10 | 1.18 | 3.08 | 3.81 | 4.46 |
| Current ratioi | 0.55 | 0.57 | 0.89 | 0.80 | 0.83 | 1.00 | 0.75 | 0.88 |
| Quick ratioi | 0.27 | 0.27 | 0.48 | 0.44 | 0.44 | 0.61 | 0.35 | 0.48 |
| Debt / assetsi | 0.00 | 21.50 | 18.85 | 19.66 | 18.72 | 16.56 | 16.67 | 15.41 |
| LT debt / equityi | -- | -- | -- | 2,783.44 | 294.40 | 103.44 | 192.12 | 104.18 |
| Interest coveragei | -1,479.06 | -- | -- | -- | -- | 14.46 | 28.49 | 58.24 |
| Revenue CAGR (3Y) %i | -- | 72.56 | 50.31 | 36.41 | 27.81 | 15.98 | 9.77 | 7.59 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | 64.67 |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | 454.43 | 275.35 | 67.60 |
| Line item | 2025-05 | 2025-08 | 2025-11 | 2026-01 | 2026-05 | 2026-08 |
|---|---|---|---|---|---|---|
| ROE %i | 76.24 | 34.48 | 59.59 | 58.68 | 63.82 | 71.99 |
| ROA %i | 12.40 | 4.86 | 6.60 | 6.98 | 8.02 | 7.98 |
| ROIC %i | 36.26 | 14.69 | 22.34 | 23.58 | 27.27 | 22.63 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 1.30 | 1.49 | 1.78 | 2.13 | 2.50 | 2.80 |
| FCF / sales %i | 3.71 | 3.75 | 3.87 | 4.46 | 4.55 | 4.35 |
| Current ratioi | 0.80 | 0.81 | 0.85 | 0.88 | 0.78 | 0.84 |
| Quick ratioi | 0.38 | 0.37 | 0.41 | 0.48 | 0.32 | 0.38 |
| Debt / assetsi | 16.34 | 15.84 | 15.87 | 15.41 | 14.65 | 29.91 |
| LT debt / equityi | 133.17 | 126.72 | 111.42 | 104.18 | 114.12 | 301.19 |
| Interest coveragei | 28.39 | 34.60 | 42.08 | 58.24 | 71.38 | 32.11 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
sale of pet products and services100.00%
Quote time 2026-10-08 08:35:40 · For reference only, not investment advice and not tailored to your situation.